Boehringer Ingelheim

03:21 EDT 26th August 2019 | BioPortfolio

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 companies, it has 41,000 employees and spends 20% of its annual sales on R&D. This is used for the following major areas; Respiratory diseases, Cardiometabolic diseases, Oncology, Neurological diseases, Immunology and Infectious diseases.

Its is active in the following areas of healthcare; Prescription Medicines, Consumer Health Care, Biopharmaceuticals, Pharmaceuticals Production and Pharma Chemicals, as well as R&D for veterinary diseases.

Source; and

Add the Boehringer Ingelheim News Channel to your RSS reader;

Follow the Boehringer Ingelheim Twitter feed;

Quick Search

review and buy Boehringer Ingelheim market research data and corporate reports here